APUS Hisse Senedi Fiyat Grafiği
APUS Kazanmak
Apimeds Pharmaceuticals US Inc
$0
0%
$0
Kapanışta: Apr 28, 16:00:00 GMT-4
$0
0%
$0
Ön Piyasa: Apr 29, 04:47:01 GMT-4
Geri
Apimeds Pharmaceuticals US Inc (APUS) Kazanmak
Önemli İstatistikler
Önceki Kapanış
--
Açılış fiyatı
--
Günün Aralığı
-
52 haftalık aralık
-
İşlem hacmi
--
Ort.Hacim
--
Dividend yield
--
EPS (TTM)
--
Piyasa Değeri
--
APUS nedir?
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
